Therapeutic Target Molecular Prediction System and Database

An AI system that predicts therapeutic target molecules based on multiple omics data (e.g., genome and transcriptome) of a disease and perturbed omics data (e.g., transcriptome in response to genetic perturbations) of target candidates, as well as a database of therapeutic target molecule candidates for over 300 diseases predicted by the system.

Decision Support for Pancreatic Cancer Resection using Tumor Marker Gene Model (TMGM)

A method to determine whether or not pancreatic cancer surgery is possible by model (TGMG) combining the conventional tumor markers DUPAN-2 and CA19-9 with the FUT2/3 genotype.

Measurement technology for very small amounts of molecules using ultrasound and aptamer sensing

Deep Learning-Based Compressed Sensing Image Reconstruction Technology

High-Performance Image Reconstruction Algorithm for Sparse Scan CT

A New Proposal for Low-Dose, High-Accuracy X-ray CT

Biomarker for Early Diagnosis of Lung Cancer

A protein whose expression is increased in extracellular vesicles (EVs) in peripheral blood of patients with early-stage lung cancer.

Ultra-bright, high-powered, small white light source

Mutant SnxA protein that binds specifically to phosphatidylinositol phosphate

Modified and artificial proteins that bind to a variety of lipid molecules can be prepared using similar techniques.

Therapeutic Drug for Achondroplasia

The approved antihistamine meclizine promotes cartilage formation by suppressing excessive signaling caused by FGFR3 mutations.